Results 191 to 200 of about 143,448 (228)

Randomised controlled trial of laparoscopic primary crural repair versus additional circular bioabsorbable mesh reinforcement in hiatal hernia (PRIME-II trial): an RCT protocol. [PDF]

BMJ Open
de Haas JWA, Geerts JH, de Boer E, Brohet RM, Hazebroek EJ, Wassenaar EB, Nieuwenhuijs VB.   +6 more
europepmc   +1 more source

Network Localization of Fatigue in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Fatigue is among the most common symptoms and one of the main factors determining the quality of life in multiple sclerosis (MS). However, the neurobiological mechanisms underlying fatigue are not fully understood. Here we studied lesion locations and their connections in individuals with MS, aiming to identify brain networks ...
Olli Likitalo, Jaakko Kungshamn, Albert Bellmunt‐Gil, Silvia Tommasin, Abhineet Ojha, Matias Viitala, Juho Aaltonen, Jyrki Lötjönen, Juha Koikkalainen, Pauli Ylikotila, Patrizia Pantano, Merja Soilu‐Hänninen, Juho Joutsa   +12 more
wiley   +1 more source

Fancl-mutant mice reveal central role of monoubiquitination in Fanconi anemia and a model for therapeutic gene editing. [PDF]

Blood Adv
Liu L, Glaser A, Isiaku AI, Fairfax K, Casolari DA, Ristovski A, Murphy V, van Twest S, Henrikus SS, Heraud-Farlow J, Granger E, Novakovic S, Monks O'Byrne SF, Tsui V, Conyers R, Gonda TJ, Crismani W, D'Andrea RJ, Heierhorst J, Deans AJ.   +19 more
europepmc   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

<i>In silico</i> detection and characterization of novel <i>Picornavirales</i> mined from publicly available insect RNA-seq data sets. [PDF]

Microbiol Spectr
Lahey Z, Jones T-KL, Simmons AM, Andreason SA.   +3 more
europepmc   +1 more source

Reduced Muscular Carnosine in Proximal Myotonic Myopathy—A Pilot 1H‐MRS Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Myotonic dystrophy type 2 (proximal myotonic myopathy, PROMM) is a progressive multisystem disorder with muscular symptoms (proximal weakness, pain, myotonia) and systemic manifestations such as diabetes mellitus, cataracts, and cardiac arrhythmias.
Alexander Gussew, Maryam Kargaran, Maik Rothe, Andreas Deistung, Dietrich Stoevesandt, Walter A. Wohlgemuth, David Strube, Thomas Kendzierski, Anna Katharina Kölsch, Maurits Gerhard Abraham Heuschen, Markus Otto, Alexander Mensch   +11 more
wiley   +1 more source

Complete mitochondrial genome of the red alga <i>Besa japonica</i> (Gigartinales, Phyllophoraceae) from Korea. [PDF]

Mitochondrial DNA B Resour
Lee SJ, Oak JH, Lee SR.
europepmc   +1 more source

Compressive sensing techniques based on secure data aggregation in WSNs. [PDF]

Sci Rep
Madkour ME, Soliman SE, Dessouky MI, Abd El-Samie FE, Hammad ME, Elsafrawey AS.   +5 more
europepmc   +1 more source

The complete mitogenome of Tylomelania sp. 'Poso A' (Caenogastropoda: Pachychilidae) from Lake Poso assembled from long-read sequencing data. [PDF]

Mol Biol Rep
Stelbrink B, Greve C, Gerheim C, Salzburger W, von Rintelen T.   +4 more
europepmc   +1 more source

Feature binding and error commission. [PDF]

Atten Percept Psychophys
Foerster A, Linz S, Moeller B, Nemeth M, Frings C, Pfister R.   +5 more
europepmc   +1 more source